Some tips for raising money in 2025
As a journalist turned investor, one of my absolute favorite ways to spend my time is to get deep with founders as they kick off a capital raise. Creating materials, including decks, memos, and a data room, can take a very long time. Not to mention the pitch prep, the investor target lists, and all the meetings. I’ve been a coach to a group of founders going through this process - and in most cases, it’s a grind.
So I asked one of our regular contributors — 7wireVentures’ Alyssa Jaffee, to share a shortlist of tips for founders embarking on a raise. And I added a few of my own, which are specific to 2025. I am wary of making predictions, but what I’ve heard from my network is that pre-seed and seed activity is going strong in health tech (especially for AI), while the hardest rounds to raise are at the Series B and C. I think of this as the “post Product Market Fit” stage of the business, but well before it’s a growth-stage round, and the bulk of the diligence will be done on Excel. At the B and C, it’s still imperative that the investor be a true believer in the business because the numbers will rarely speak for themselves.
Bottom line: Anything without AI that’s more services-oriented will need to find the right fit in the venture capital world. There are certainly still a lot of investors who can get behind these businesses, but there’s more discipline now than ever before about valuation. These companies should not be valued like software businesses because they’re not.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
AMA with Doximity CEO Jeff Tangney
Join Doximity CEO Jeff Tangney for a live Q&A on where clinicians are finding value with AI, how Doximity has evolved, and building a company from zero to IPO.
Office Hours
A live Q&A with Christina Farr and Ruth Reader, exclusively for Second Opinion Premium members. Thursday, November 19, 1:30–2:30 p.m. ET / 10:30–11:30 a.m. PT.
The Shift Left & the Impact of the Midterms on Healthcare
Democrats just took both chambers. Aneesh Chopra, Christopher Kerns and Mike Desjadon join Ruth Reader and Christina Farr live to talk through what they'll try to do on healthcare — and what's actually achievable under a Republican White House.
Is It Finally the Moment for Alternative Health Plans?
Register Here Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
Register Here The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&